Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040
Although the global mortality rate and DALY rate for prostate cancer show a decreasing trend, the number of new cases, deaths, and DALYs continues to rise due to global population growth and the aging population, and the disease burden remains significant. Furthermore, there are substantial geographic disparities in the disease burden of prostate cancer. Therefore, targeted programs should be implemented to strengthen prostate cancer diagnosis and treatment in these specific regions.
Authors
- Lumin Chen (ORCID: https://orcid.org/0009-0006-7901-3040)
- Qing Guan (ORCID: https://orcid.org/0000-0003-4687-4275)
- Qing Ji (ORCID: https://orcid.org/0000-0002-1899-0204)
- Yuning Ma (ORCID: https://orcid.org/0000-0002-4435-1174)
- Jinzhong Ji (ORCID: https://orcid.org/0009-0004-7119-9261)
- Meili Sun (ORCID: https://orcid.org/0000-0002-4914-6508)
- Hui Zhou (ORCID: https://orcid.org/0000-0002-6318-894X)
- Xiuquan Lin (ORCID: https://orcid.org/0009-0009-1935-9869)
- Zhijie Chen (ORCID: https://orcid.org/0000-0003-0627-0856)
- Yichun Zheng (ORCID: https://orcid.org/0000-0002-7881-5344)
- Feifan Chu (ORCID: https://orcid.org/0009-0006-9390-6240)
- Haihan Song (ORCID: https://orcid.org/0009-0006-7753-8628)
- Tingyang Huang
Institutions
- Fujian Medical University (CN)
- Beijing University of Technology (CN)
- Pudong New Area People's Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1186/s12957-025-03733-1
- Citations
- 21
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 31.89
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Technology Project